AVXL News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

AV

Mkt Cap

$120.6M

Volume

1.41M

Next Earnings

November 24th

Loading chart

AV

AVXLAnavex Life Sciences

AVXL

Pay with—

Available Balance0.00

AV

Mkt Cap

$121.4M

Volume

1.41M

Next Earnings

November 24th

Chart Financials Earnings News About Insider Filings

AVXL Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Anavex Life Sciences Corp. Class Action LawsuitRobbins LLP announced a class action lawsuit against Anavex Life Sciences Corp. for allegedly misleading investors about inadequate internal controls and regulatory challenges related to former CEO Christopher Missling's misconduct. The lawsuit covers investors who purchased AVXL securities between November 26, 2025 and August 28, 2026. The lead plaintiff deadline is November 30, 2026.GlobeNewswire Inc. · Oct 13, 2026

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXLRosen Law Firm is reminding investors in Anavex Life Sciences, Ardelyx, and AST SpaceMobile to join securities class action lawsuits before upcoming deadlines. The lawsuits allege that these companies made false or misleading statements regarding their business operations, internal controls, and regulatory challenges. Investors who purchased securities during specified class periods may be entitled to compensation.GlobeNewswire Inc. · Oct 11, 2026

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDXRosen Law Firm is soliciting investors who purchased securities of Ardelyx, Inc., Anavex Life Sciences Corp., and AST SpaceMobile, Inc. during specified periods to join class action lawsuits. The firm alleges these companies made materially false statements regarding commercial performance and growth prospects. Investors have until November 16, 2026 to serve as lead plaintiffs.GlobeNewswire Inc. · Oct 11, 2026

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXLRosen Law Firm has filed a securities class action lawsuit against Anavex Life Sciences Corp. (AVXL) on behalf of investors who purchased securities between November 26, 2025 and August 28, 2026. The lawsuit alleges that Anavex made false and misleading statements regarding inadequate internal controls, understated regulatory challenges related to misconduct by former CEO Christopher Missling, and misrepresented the company's business and prospects. The lead plaintiff deadline is November 30, 2026.GlobeNewswire Inc. · Oct 9, 2026

AVXL INVESTORS: Contact Kirby McInerney LLP About the Securities Fraud Lawsuit Filed on Behalf of Anavex Life Sciences Corp. ShareholdersKirby McInerney LLP has filed securities fraud class action lawsuits against Anavex Life Sciences Corp. for allegedly making false statements and failing to disclose inadequate internal controls and regulatory challenges related to former CEO Christopher Missling's misconduct. The lawsuit covers investors who purchased securities between November 26, 2025 and August 28, 2026. Anavex's stock declined significantly following disclosures about the CEO's termination, delayed SEC filings, and material weaknesses in internal controls.GlobeNewswire Inc. · Oct 7, 2026

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Tigo Energy, Inc. (TYGO), Fluence Energy, Inc. (FLNC), and Anavex Life Sciences Corp. (AVXL) Announced by Holzer & Holzer, LLCHolzer & Holzer, LLC announced lead plaintiff deadlines for multiple shareholder class action lawsuits. Tigo Energy faces allegations of false statements regarding an EG4 Electronics partnership (deadline: November 23, 2026). Fluence Energy is accused of misleading statements about production capabilities and revenue guidance (deadline: November 30, 2026). Anavex Life Sciences faces allegations of inadequate internal controls and understated regulatory challenges related to former CEO misconduct (deadline: November 30, 2026).GlobeNewswire Inc. · Oct 6, 2026

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Qfin Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QFINRosen Law Firm has filed class action lawsuits against Qfin Holdings, Inc. and Anavex Life Sciences Corp. on behalf of investors who purchased securities during specified periods. The Qfin lawsuit alleges defendants made false statements about business resilience and downplayed regulatory impacts. Investors have until November 30, 2026 to move the court to serve as lead plaintiff.GlobeNewswire Inc. · Oct 5, 2026

ANAVEX CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corp. and Encourages Investors to Contact the FirmA class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) in the U.S. District Court for the Southern District of New York. The complaint alleges that the company and its executives violated federal securities laws by making false and misleading statements regarding adequate internal controls, understating regulatory challenges related to misconduct by former CEO Christopher Missling, and misrepresenting the company's business and prospects. Investors who purchased Anavex securities between November 26, 2025 and August 28, 2026 may be eligible to participate in the lawsuit.GlobeNewswire Inc. · Oct 5, 2026

ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXLRosen Law Firm has filed a class action lawsuit against Anavex Life Sciences Corp. (AVXL) on behalf of investors who purchased securities between November 26, 2025 and August 28, 2026. The lawsuit alleges that the company made false and misleading statements regarding adequate internal controls, understated regulatory challenges related to misconduct by former CEO Christopher Missling, and misrepresented its business operations and prospects. Investors have until November 30, 2026 to move the court to serve as lead plaintiff.GlobeNewswire Inc. · Oct 2, 2026

Bronstein, Gewirtz & Grossman LLC Urges Anavex Life Sciences Corp. Investors to Act: Class Action Filed Alleging Investor HarmA class action lawsuit has been filed against Anavex Life Sciences Corp. alleging securities fraud. The complaint claims the company made false statements about its business operations, lacked adequate internal controls, and understated regulatory challenges related to misconduct by former CEO Christopher Missling. The class period covers November 26, 2025 to August 28, 2026, and investors have until November 30, 2026 to request lead plaintiff status.GlobeNewswire Inc. · Oct 1, 2026

to start trading

AV

AVXLAnavex Life Sciences

AVXL

Pay with—

Available Balance0.00

Your PositionYou don't own any AVXL yet.

Related Tickers

Earnings